High-fat, carbohydrate-free diet markedly aggravates obesity but prevents β-cell loss and diabetes in the obese, diabetes-susceptible db/db strain

Obesity Facts

Volumn 1, Issue 6, 2008, Pages 292-297

  Mirhashemi, Farshad ^a   Kluth, Oliver ^a   Scherneck, Stephan ^a   Vogel, Heike ^a   Kluge, Reinhart ^a   Schürmann, Annette ^a   Joost, Hans Georg ^a   Neschen, Susanne ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Cell; Carbohydrates; Diabetes; Diet; Glucotoxicity

Indexed keywords

GLUCOSE TRANSPORTER 2; INSULIN;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CARBOHYDRATE DIET; CHEMISTRY; FAT INTAKE; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KINETICS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PATHOLOGY;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DIETARY FATS; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TRANSPORTER TYPE 2; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; KINETICS; MALE; MICE; MICE, INBRED C57BL; OBESITY;

EID: 75649130804     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000176064     Document Type: Article

References (31)

1. Leahy JL, Bonner-Weir S, Weir G: Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucoseinduced insulin secretion. Diabetes Care 1992;15: 442-455.
2. Yki-Jarvinen H: Glucose toxicity. Endocr Rev 1992;13:415-431.
3. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A: Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 2001;50(suppl 1):S154-159. (Pubitemid 32148243)
4. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH: Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A 1994;91: 10878-10882.
5. Unger RH: Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003;144: 5159-5165. (Pubitemid 37476041)
6. Poitout V, Robertson RP: Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 2008; 29:351-366. (Pubitemid 351679704)
7. Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL: Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005;54(suppl 2): S97-107.
8. Plum L, Giesen K, Kluge R, Junger E, Linnartz K, Schürmann A, Becker W, Joost HG: Characterization of the diabetes susceptibility locus Nidd/SJL in the New Zealand obese (NZO) mouse: Islet cell destruction, interaction with the obesity QTL Nob1, and effect of dietary fat. Diabetologia 2002; 45:823-830.
9. Jürgens H, Neschen S, Ortmann S, Scherneck S, Schmolz K, Schüler G, Schmidt S, Blüher M, Klaus S, Perez-Tilve D, Tschöp M, Schürmann A, Joost HG: Development of diabetes in obese, insulinresistant mice: essential role of dietary carbohydrate in β-cell destruction. Diabetologia 2007;50: 1481-1489. (Pubitemid 46879001)
10. Ortlepp JR, Kluge R, Giesen K, Plum L, Radke P, Hanrath P, Joost HG: A metabolic syndrome of hypertension, hyperinsulinemia, and hypercholesterolemia in the New Zealand Obese (NZO) mouse. Eur J Clin Invest 2000;30:195-202. (Pubitemid 30153659)
11. Leiter EH, Reifsnyder PC, Flurkey K, Partke HJ, Junger E, Herberg L: NIDDM genes in mice.Deleterious synergism by both parental genomes contributes to diabetic thresholds. Diabetes 1998;47: 1287-1295. (Pubitemid 28357007)
12. Plum L, Kluge R, Giesen K, Altmüller J, Ortlepp JR, Joost HG: Type-2-diabetes-like hyperglycaemia in a backcross model of New Zealand Obese (NZO) and SJL mice: Characterization of a susceptibility locus on chromosome 4 and its relation with obesity. Diabetes 2000;49:1590-1596.
13. Reifsnyder PC, Leiter EH: Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice. Diabetes 2002;51:825-832. (Pubitemid 34760196)
14. Leiter EH, Coleman DL, Ingram DK, Reynolds MA: Influence of dietary carbohydrate on the induction of diabetes in C57BL/KsJ-db/db diabetes mice. J Nutr 1983;113:184-195. (Pubitemid 13130663)
15. Tinsley FC, Taicher GZ, Heiman ML:Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes Res 2004;12:150-160. (Pubitemid 41137499)
16. Jürgens HS, Schürmann A, Kluge R, Ortmann S, Klaus S, Joost HG, Tschöp MH: Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand Obese mice. Physiol Genomics 2006;13:234-241.
17. Hellwig B, Brown FM, Schürmann A, Shanahan MF, Joost HG: Localization of the binding domain of the inhibitory ligand forskolin in the glucose transporter GLUT4 by photolabeling, proteolytic cleavage and a site-specific antiserum. Biochim Biophys Acta 1992;1111:178-184.
18. Igel M, Kainulainen H, Brauers A, Becker W, Herberg L, Joost HG: Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawley rats) and obese (db/db mice, fa/fa rats) rodents. Diabetologia 1996;39:758-765. (Pubitemid 26228104)
19. Coleman DL: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978;14:141-148. (Pubitemid 8286141)
20. Dokmanovic-Chouinard M, Chung WK, Chevre JC, Watson E, Yonan J, Wiegand B, Bromberg Y, Wakae N, Wright CV, Overton J, Ghosh S, Sathe GM, Ammala CE, Brown KK, Ito R, LeDuc C, Solomon K, Fischer SG, Leibel RL: Positional cloning of 'Lisch-Like', a candidate modifier of susceptibility to type 2 diabetes in mice. PLoS Genet 2008;4:e1000137.
21. Schmidt C, Gonzaludo NP, Strunk S, Dahm S, Schuchhard J, Kleinjung F, Wuschke S, Joost HG, Al-Hasani H: A metaanalysis of QTL for diabetes related traits in rodents. Physiol Genomics 2008; 34:42-53.
22. Jörns A, Tiedge M, Sickel E, Lenzen S: Loss of GLUT2 glucose transporter expression in pancreatic beta cells from diabetic Chinese hamsters. Virchows Arch 1996;428:177-185. (Pubitemid 26237448)
23. Jörns A, Tiedge M, Ziv E, Shafrir E, Lenzen S: Gradual loss of pancreatic beta-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time course of nutritionally induced type-2 diabetes in Psammomys obesus (sand rat). Virchows Arch 2002;440:63-69. (Pubitemid 34143351)
24. Chankiewitz E, Peschke D, Herberg L, Bazwinsky I, Mühlbauer E, Brömme HJ, Peschke E: Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand Obese mouse (NZO/Hl)? Exp Clin Endocrinol Diabetes 2006; 114:262-269. (Pubitemid 44065180)
25. Junger E, Herberg L, Jeruschke K, Leiter EH: The diabetes-prone NZO/Hl strain. II. Pancreatic immunopathology. Lab Invest 2002;82:843-853. (Pubitemid 34761659)
26. Poitout V, Hagman D, Stein R, Artner I, Robertson RP, Harmon JS: Regulation of the insulin gene by glucose and fatty acids. J Nutr 2006;136:873-876.
27. Harmon JS, Stein R, Robertson RP: Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J Biol Chem 2005;280:11107-11113. (Pubitemid 40418415)
28. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC: Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-797.
29. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB: Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004;292:927-934. (Pubitemid 39097202)
30. Heidemann C, Hoffmann K, Spranger J, Klipstein- Grobusch K, Möhlig M, Pfeiffer AF, Boeing H: A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study cohort. Diabetologia 2005;48:1126-1134. (Pubitemid 40909648)
31. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M: STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-2077.